Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Source: nct - Country: Netherlands,Spain,Austria,Ukraine,Czech Republic,France,United Kingdom,Slovakia,Poland - Phase: terminated - Promoter: nct
nct
Update Il y a 5 ans
Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome
The purpose of the protocol is to assess the efficacy and safety of BIM 23A760 on patient's overall satisfaction in terms of symptom relief (diarrhoea and/or flushes) in patients with carcinoid syndrome after 24 weeks of treatment.
Country
Austria
,
Belgium
,
Czech Republic
,
Finland
,
France
,
Germany
,
Ireland
,
Israel
,
Italy
,
Latvia
,
Netherlands
,
Poland
,
Russian Federation
,
Slovakia
,
Spain
,
Sweden
,
Ukraine
,
United Kingdom
,
organs
None
Specialty
None
Closed trial
More information
1